136 related articles for article (PubMed ID: 194536)
21. Malignant glucagonoma syndrome: response to chemotherapy.
Marynick SP; Fagadau WR; Duncan LA
Ann Intern Med; 1980 Sep; 93(3):453-4. PubMed ID: 6254416
[TBL] [Abstract][Full Text] [Related]
22. [The glucagonoma syndrome].
Rappersberger K; Wolff-Schreiner E; Konrad K; Wolff K
Hautarzt; 1987 Oct; 38(10):589-98. PubMed ID: 2824404
[TBL] [Abstract][Full Text] [Related]
23. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
Vandersteen PR; Scheithauer BW
J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
[TBL] [Abstract][Full Text] [Related]
24. Clinical aspects of glucagon-producing islet cell tumors.
Prinz RA; Dorsch TR; Lawrence AM
Am J Gastroenterol; 1981 Aug; 76(2):125-31. PubMed ID: 6272569
[TBL] [Abstract][Full Text] [Related]
25. Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review.
Kasper CS
Cutis; 1992 Feb; 49(2):120-2, 125-8. PubMed ID: 1563284
[TBL] [Abstract][Full Text] [Related]
26. [Necrolytic migratory erythema as the first manifestation of glucagonoma].
Chang CH; Sheu HM; Cheng GS; Yu HS
J Formos Med Assoc; 1991 Dec; 90(12):1240-5. PubMed ID: 1686896
[TBL] [Abstract][Full Text] [Related]
27. Glucagonoma syndrome.
Bloom SR; Polak JM
Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
[TBL] [Abstract][Full Text] [Related]
28. Necrolytic migratory erythema, presenting as candidiasis, due to a pancreatic glucagonoma.
Katz R; Fischmann AB; Galotto J; Guccio JG; Higgins GA; Ortega LG; West WH; Recant L
Cancer; 1979 Aug; 44(2):558-63. PubMed ID: 476569
[TBL] [Abstract][Full Text] [Related]
29. [The course of diabetes and clinical findings in glucagonoma].
Teuscher A; Studer PP; Krebs A; Berger M; Aeberhard P
Schweiz Med Wochenschr; 1979 Sep; 109(35):1273-80. PubMed ID: 524094
[TBL] [Abstract][Full Text] [Related]
30. A glucagon-secreting alpha-cell carcinoma of the pancreas.
McGavran MH; Unger RH; Recant L; Polk HC; Kilo C; Levin ME
N Engl J Med; 1966 Jun; 274(25):1408-13. PubMed ID: 4286757
[No Abstract] [Full Text] [Related]
31. Histologic variation in the skin lesions of the glucagonoma syndrome.
Kheir SM; Omura EF; Grizzle WE; Herrera GA; Lee I
Am J Surg Pathol; 1986 Jul; 10(7):445-53. PubMed ID: 3014912
[TBL] [Abstract][Full Text] [Related]
32. [A glucagon-secreting alpha-cell carcinoma of the pancreas].
Matsumoto J; Noto N; Kikuchi Y; Kitazima S; Kaimori M; Sasaki G; Ohto T; Nakamura K
Nihon Shokakibyo Gakkai Zasshi; 1985 Feb; 82(2):330-4. PubMed ID: 2987580
[No Abstract] [Full Text] [Related]
33. Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid.
Peterson LL; Shaw JC; Acott KM; Mueggler PA; Parker F
J Am Acad Dermatol; 1984 Sep; 11(3):468-73. PubMed ID: 6090515
[TBL] [Abstract][Full Text] [Related]
34. Neurologic involvement in glucagonoma syndrome: response to combination chemotherapy with 5-fluorouracil and streptozotocin.
Khandekar JD; Oyer D; Miller HJ; Vick NA
Cancer; 1979 Dec; 44(6):2014-6. PubMed ID: 228832
[TBL] [Abstract][Full Text] [Related]
35. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of glucagon in islet cell adenomas of the pancreas by immunofluorescent technic.
Lomský R; Langr F; Vortel V
Am J Clin Pathol; 1969 Feb; 51(2):245-50. PubMed ID: 4304016
[No Abstract] [Full Text] [Related]
37. Glucagonoma presenting as morbid obesity.
Martin FM; Hamilton W; Dons R; Cashell AW; Ghosh BC
J Surg Oncol; 1988 Dec; 39(4):256-9. PubMed ID: 2848156
[TBL] [Abstract][Full Text] [Related]
38. Response of glucagonomas to surgical excision and chemotherapy. Report of two cases and review of the literature.
Reyes-Govea J; Holm A; Aldrete JS
Am Surg; 1989 Aug; 55(8):523-7. PubMed ID: 2548427
[TBL] [Abstract][Full Text] [Related]
39. The glucagonoma syndrome and its management.
Kessinger A; Lemon HM; Foley JF
J Surg Oncol; 1977; 9(5):419-24. PubMed ID: 201809
[TBL] [Abstract][Full Text] [Related]
40. [Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
Kitoh M; Ohyama K; Shigeo ; Arao AT
Nihon Hifuka Gakkai Zasshi; 1981 Apr; 91(5):559-68. PubMed ID: 6270429
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
